What is IPO Grey Market Premium (GMP)?

IPO Grey Market Premium (GMP) is an unofficial, over-the-counter premium over the issue price that dealers and investors pay prior to official listing on NSE/BSE.

How is estimated IPO listing price determined?

Estimated Listing Price = Cut-off / Issue Price + Current Grey Market Premium (GMP). For example, an issue price of ₹100 with ₹40 GMP yields an estimated listing price of ₹140 (+40%).

What is Kostak rate in an IPO?

Kostak rate is the fixed profit earned by selling an IPO application before allotment, irrespective of whether the application is allotted shares or not.

What is Subject to Sauda in IPO trading?

Subject to Sauda is an informal contract where payment is made only if the seller receives share allotment in the IPO.

Is IPO Grey Market Premium (GMP) regulated by SEBI?

No. Grey Market transactions are non-exchange over-the-counter commitments and are not officially regulated or endorsed by SEBI. Investors should treat GMP as an informal sentiment indicator.

What is the current subscription status of Chandan Healthcare Limited IPO?

Chandan Healthcare Limited IPO has received a total subscription of 7.11 times overall.

IPO GreyPremiumLIVE

Grey Market Intelligence

Chandan Healthcare Limited

ListedSME

Healthcare / Pharmaceuticals · NSE

Established in September 2003, Chandan Healthcare Limited is a leading diagnostic network in North India, offering a wide range of pathology and radiology services. The company operates a flagship lab, seven central labs, 26 satellite centres, and over 300 collection centres across 23 cities in Uttar Pradesh and more than 19 in Uttarakhand. Its portfolio includes 1,496 tests covering routine pathology, specialized diagnostics, and advanced imaging such as X-rays, CT scans, MRIs, and ultrasounds. Supported by a team of radiologists, pathologists, and skilled professionals, Chandan Healthcare is dedicated to providing accurate, reliable, and accessible diagnostic services across its growing network.

Price Band

₹151 – ₹159

Issue Size

₹107 Cr

Lot Size

800 shares

GMP

—

Est. Listing

₹159

at current GMP

Subscribed

7.11x

overall

Open

10 Feb 2025

12 Feb 2025

Allotment

13 Feb 2025

Refund

14 Feb 2025

Demat Credit

15 Feb 2025

Listing

17 Feb 2025

Last updated 12 days ago

Overview Live GMP Subscription Status Allotment Status Filing Documents

Overall Subscription

7.11x

Total Demand

QIB Multiplier

7.58x

Institutions & Funds

NII / HNI

19.22x

High Net-Worth

Retail (RII)

2.44x

Individual Bidders

Category-Wise Subscription Breakup

Live bidding breakdown by institutional, non-institutional, and retail investors

Total 7.11x

Category	Shares Offered	Shares Applied / Bid	Times Subscribed
QIB	1,233,600	9,356,800	7.58x
NIB	925,600	17,791,200	19.22x
RETAIL	2,159,200	5,272,800	2.44x
EMPLOYEES	245,600	51,200	0.21x
Total	4,564,000	32,472,000	7.11x

Application-Wise Breakup

Total unique applications received across retail and HNI tranches

Category	Applications Reserved	Applications Received	Times Subscribed
QIB	—	12	0.00x
NIB	—	457	0.00x
RETAIL	—	6,591	0.00x
EMPLOYEES	—	39	0.00x

Day-Wise Subscription Progress

Track continuous institutional and retail bidding order books for all active issues on the ipo live subscription feed.

About Chandan Healthcare Limited Public Issue & Market Profile

Chandan Healthcare Limited is bringing an initial public offering (IPO) in the Healthcare / Pharmaceuticals sector with an aggregate issue size of ₹107.36 Crores. The shares are offered at a price band of ₹151 to ₹159 per equity share on NSE. Currently, traders and retail applicants are calculating expected listing gains and break-even points based on unofficial grey market quotations.

Bidding & Quota Instructions:

Prospective investors can apply in the retail quota with a minimum of 1 lot comprising 800 shares (approx. ₹1,27,200 minimum investment). High net-worth individuals (HNI/NII) can bid in the sHNI (₹2 Lakh to ₹10 Lakh) or bHNI (above ₹10 Lakh) categories for enhanced quota allocation.

Allotment Reconciliation Schedule:

Allotment reconciliation will be managed by Kfin Technologies Limited. Eligible allottees will receive credit of equity shares into their Demat accounts by 2025-02-15, while un-allotted funds or UPI block mandates will be released on 2025-02-14.

Frequently Asked Questions

What is Chandan Healthcare Limited IPO GMP today?

Currently, Chandan Healthcare Limited IPO Grey Market Premium (GMP) is not actively quoted or is quoted flat at ₹0. The shares are expected to list close to the issue price band of ₹151 to ₹159 per equity share.

What is the expected profit per lot for Chandan Healthcare Limited IPO?

The retail lot size is 800 shares requiring a minimum application amount of ₹1,27,200. Expected listing price is ₹159 per equity share.

What is the issue size and price band for Chandan Healthcare Limited IPO?

The Chandan Healthcare Limited IPO aggregate issue size is ₹107.36 Crores with an equity price band set at ₹151 to ₹159 per equity share. The retail lot size is 800 shares requiring a minimum capital outlay of approx. ₹1,27,200.

How can I check Chandan Healthcare Limited IPO live subscription demand?

Live subscription figures are compiled real-time from the NSE and BSE bidding engines. Currently, overall subscription is 7.11x (Retail: 2.44x, QIB: 7.58x, NII: 19.22x). You can track live multiples directly on our dedicated subscription page.

Where and when will Chandan Healthcare Limited IPO allotment status be published?

The basis of allotment will be published on the official registrar portal (Kfin Technologies Limited) and the BSE status verification website on or around 2025-02-13. Investors can verify status using PAN card or application number.

When is the listing date for Chandan Healthcare Limited IPO?

Chandan Healthcare Limited shares are scheduled to list on NSE on 2025-02-17.